Updated on 17 November 2026
Joint R&D with a Japanese SME: special delivery system for targeted cancer therapy
Owner & Founder at Avigail Lab Meditech Group Ltd
Jerusalem, Israel
About
Joint R&D with a Japanese partner (Eureka Globalstars Japan 2026): we are seeking a Japanese SME to collaborate on the development and validation of our special delivery system for targeted cancer therapy - a drug-delivery technology platform. Ideal partner: expertise in drug-delivery systems, formulation engineering, advanced materials, or preclinical testing technologies. The Israeli company leads the research; IP remains with the Israeli company as required by the Israel Innovation Authority; the Japanese partner's costs are funded by NEDO (up to 2/3, up to JPY 100M per project).
Stage
- Early
Topic
- Biotechnology
Type
- Research
- Technical
Similar opportunities
Project cooperation
- Planning
- Research
- Technical
- Artificial Intelligence
Naoto Kawabe
Founding Product Manager at Optiroq
Luxembourg, Luxembourg
Project cooperation
Japanese SME partner sought for AI soundscaping R&D in workplaces
- Planning
- Research
- Technical
- Artificial Intelligence
Evan Benway
Founder & CEO at Moodsonic
London, United Kingdom
Project cooperation
CrystalForm-AI — Japan–Spain Joint R&D in Computational Molecular Crystal Analysis
- Planning
- Research
- Technical
- New Materials
- Artificial Intelligence
Pavlo Bondarenko
Managing Director & Research Lead at BUENAUDA, S.L.
Barcelona, Spain